Table 3.
Clinical manifestations and laboratory test results of patients with encephalitis.
| Patient number | Gender | Age | Encephalopathy | Fever | Seizure | Neurology signs | Elevated CSF leukocytes | EEG | Neuro-imaging | Diagnosis | SRS in follow-up |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 27 | + | + | GTCS, Myocl, SPS, PS | + | + | Diffuse abnormity | – | Anti-NMDAR encephalitis | SPS, CPS |
| 2 | M | 36 | + | + | – | – | + | – | Bilateral frontal and temporal lobe lesions | Bacterial meningoe-ncephalitis | SPS |
| 3 | M | 49 | + | + | – | – | + | – | – | Viral encephalitis | – |
| 4 | M | 17 | + | + | GTCS | – | + | – | – | Viral encephalitis | – |
| 5 | M | 36 | + | + | GTCS | – | + | Diffuse abnormity | Bilateral temporal and occipital lobe lesion with enhancement | Viral encephalitis | – |
| 6 | M | 22 | + | + | – | + | – | Diffuse abnormity | – | Viral encephalitis | – |
| 7 | F | 24 | + | + | GTCS, SPS, CPS | + | + | Diffuse abnormity | Bilateral frontal, temporal lobe lesion | Viral encephalitis | GTCS,SPS,CPS |
| 8 | M | 77 | + | + | SPS, Myocl | – | + | Diffuse abnormity | – | Viral encephalitis | SPS |
| 9 | M | 28 | + | + | GTCS, Myocl, SPS, CPS | – | + | Diffuse abnormity | – | Viral encephalitis | GTCS,Myocl,SPS,CPS,AB |
| 10 | F | 46 | + | + | – | – | + | Diffuse abnormity | – | Viral encephalitis | – |
| 11 | M | 36 | + | + | GTCS | – | + | – | – | Viral encephalitis | – |
| 12 | M | 32 | + | + | – | – | + | – | – | Viral encephalitis | – |
SPS, single partial seizure; CPS, complex partial seizure; GTCS, generalized tonic-clonic seizure; Myocl, Myoclonic; AB, absence attack.